Close X
Tuesday, November 19, 2024
ADVT 
National

What is meningococcal meningitis? Some questions and answers about the disease

Darpan News Desk The Canadian Press, 13 Feb, 2015 10:42 AM

    HALIFAX — Here are some questions and answers about meningococcal meningitis:

    Question: What is it?

    Answer: Meningococcal meningitis is an inflammation of the lining of the brain and spinal cord spread by bacteria.

    Q: Who can get it?

    A: Anyone, but those most at risk include children under five, adolescents between 15 and 18 years of age and people living in close quarters. In Canada, less than one person in every 100,000 gets it. It can cause death in up to 10 per cent of those infected.

    Q: How do people get infected?

    A: It is spread by direct contact with secretions from the nose and mouth through activities such as kissing and sharing food, drinks, eating utensils, cigarettes and toothbrushes. Infection often happens during the winter and spring months.

    Q: What are the symptoms?

    A: Symptoms may include sudden fever, headache, change in level of alertness, stiff neck, rash, nausea, vomiting and increased sensitivity to light.

    Q: If someone is vaccinated against meningitis, how can it be a problem for them?

    A: There are five strains of meningitis that cause the deadly forms of the disease: A, B, C, Y and W-135. Healthy infants are vaccinated against the C strain. Adolescents and young adults get a booster shot for the C strain and another shot to protect against the A, Y and W-135 strains. Vaccines for the B strain exist but aren't routinely given in Canada.

    Q: What is the treatment for those infected?

    A: Bacterial meningitis can be treated with antibiotics. Early diagnosis and treatment are important.

    MORE National ARTICLES

    Jian Ghomeshi will plead not guilty to sexual assault charges: Lawyer

    Jian Ghomeshi will plead not guilty to sexual assault charges: Lawyer
    TORONTO — A sombre Jian Ghomeshi stood silently by his lawyer on Wednesday as she told a large crowd of reporters at a Toronto courthouse that the former CBC Radio host would plead not guilty to multiple counts of sexual assault.

    Jian Ghomeshi will plead not guilty to sexual assault charges: Lawyer

    'Curious' Workers Fired For Sneaking Looks At 112 Private E-Health Records

    'Curious' Workers Fired For Sneaking Looks At 112 Private E-Health Records
    VICTORIA — Vancouver Island's health authority has fired two employees it says peaked at patients' private health files to satisfy their personal curiosity.

    'Curious' Workers Fired For Sneaking Looks At 112 Private E-Health Records

    CBC, NHL websites briefly affected by Syrian Electronic Army hack

    CBC, NHL websites briefly affected by Syrian Electronic Army hack
    TORONTO — A group of politically motivated hackers operating under the name the Syrian Electronic Army briefly defaced the websites of the CBC, the NHL and a number of other prominent news outlets on Thursday.

    CBC, NHL websites briefly affected by Syrian Electronic Army hack

    Liberals Use Legislature To Set Stage For LNG, But Still No Deals

    Liberals Use Legislature To Set Stage For LNG, But Still No Deals
    VICTORIA — The stage has been set for the development of a liquefied natural gas industry by British Columbia's Liberal government, even though the first of what it says are 18 potential deals has yet to come to fruition.

    Liberals Use Legislature To Set Stage For LNG, But Still No Deals

    Advocates for sexual assault victims encouraged by Ghomeshi charges

    Advocates for sexual assault victims encouraged by Ghomeshi charges
    TORONTO — The sexual assault charges filed against former CBC Radio host Jian Ghomeshi offer tentative hope to those who fear their claims will be dismissed by an indifferent law enforcement system, victims' advocates said Wednesday.

    Advocates for sexual assault victims encouraged by Ghomeshi charges

    U.S. Ebola vaccine looks protective but may require high dose: study

    U.S. Ebola vaccine looks protective but may require high dose: study
    TORONTO — A single dose of a U.S.-designed Ebola vaccine may be protective against the disease, a new study suggests. But the research also appears to indicate that dose will have to be relatively large, which may present problems for the vaccine.

    U.S. Ebola vaccine looks protective but may require high dose: study